[Molecular biomarkers in breast cancer : advances in precision medicine].

Revue medicale de Liege Pub Date : 2025-01-01
Charlotte Lardinois, Valérie Bleret, Denis Danthine, Éric Lifrange, Guy Jerusalem, Pino Cusumano
{"title":"[Molecular biomarkers in breast cancer : advances in precision medicine].","authors":"Charlotte Lardinois, Valérie Bleret, Denis Danthine, Éric Lifrange, Guy Jerusalem, Pino Cusumano","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer is a complex disease influenced by genetic and environmental factors. Molecular profiling research has revealed significant diversity within the disease, including among tumours with similar morphological features. This diversity can lead to significant differences in tumour behaviour. Scientists have turned their attention to molecular biomarkers to predict cancer behaviour and/or response to treatment, and to ensure personalised, optimal management of breast cancer patients. This article presents four examples of molecular biomarkers and genetic tests used in the field of breast cancer, highlighting their latest advances and their clinical use as predictive and/or prognostic markers.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 1","pages":"42-47"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale de Liege","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Breast cancer is a complex disease influenced by genetic and environmental factors. Molecular profiling research has revealed significant diversity within the disease, including among tumours with similar morphological features. This diversity can lead to significant differences in tumour behaviour. Scientists have turned their attention to molecular biomarkers to predict cancer behaviour and/or response to treatment, and to ensure personalised, optimal management of breast cancer patients. This article presents four examples of molecular biomarkers and genetic tests used in the field of breast cancer, highlighting their latest advances and their clinical use as predictive and/or prognostic markers.

[乳腺癌的分子生物标志物:精准医学的进展]。
乳腺癌是一种受遗传和环境因素影响的复杂疾病。分子谱研究揭示了该疾病的显著多样性,包括具有相似形态特征的肿瘤。这种多样性会导致肿瘤行为的显著差异。科学家们已经将注意力转向分子生物标志物,以预测癌症行为和/或对治疗的反应,并确保对乳腺癌患者进行个性化的最佳管理。本文介绍了在乳腺癌领域中使用的分子生物标志物和基因检测的四个例子,重点介绍了它们的最新进展及其作为预测和/或预后标志物的临床应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信